Clinical Trial Update: Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial evaluating the safety and tolerability of RTX-GRT7039 injections for knee osteoarthritis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Osteoarthritis of the Knee

Drugs mentioned

• RTX-GRT7039

Snippet

Sponsor: Grünenthal GmbH | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2025-11-28